SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-289752
Filing Date
2014-07-31
Accepted
2014-07-31 16:30:56
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d757677d10q.htm 10-Q 440420
2 EX-10.1 d757677dex101.htm EX-10.1 20194
3 EX-31.1 d757677dex311.htm EX-31.1 5957
4 EX-31.2 d757677dex312.htm EX-31.2 5889
5 EX-32.1 d757677dex321.htm EX-32.1 3381
6 EX-32.2 d757677dex322.htm EX-32.2 3366
  Complete submission text file 0001193125-14-289752.txt   2749098

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idix-20140630.xml EX-101.INS 282554
8 XBRL TAXONOMY EXTENSION SCHEMA idix-20140630.xsd EX-101.SCH 32104
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idix-20140630_cal.xml EX-101.CAL 42219
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idix-20140630_def.xml EX-101.DEF 155463
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idix-20140630_lab.xml EX-101.LAB 234037
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idix-20140630_pre.xml EX-101.PRE 185012
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 141006652
SIC: 2834 Pharmaceutical Preparations